IonQ, Inc. (NYSE:IONQ – Get Free Report) insider John Raymond sold 2,800 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $33.34, for a total transaction of $93,352.00. Following the completion of the transaction, the insider directly owned 83,963 shares in the company, valued at approximately $2,799,326.42. This represents a 3.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
IonQ Trading Down 2.7%
NYSE:IONQ opened at $32.39 on Thursday. The firm’s fifty day simple moving average is $39.14 and its 200 day simple moving average is $49.87. IonQ, Inc. has a twelve month low of $18.81 and a twelve month high of $84.64. The firm has a market capitalization of $11.88 billion, a price-to-earnings ratio of -13.01 and a beta of 2.61.
Hedge Funds Weigh In On IonQ
Institutional investors have recently added to or reduced their stakes in the company. Archer Investment Corp grew its stake in shares of IonQ by 119.3% during the second quarter. Archer Investment Corp now owns 592 shares of the company’s stock valued at $25,000 after acquiring an additional 322 shares in the last quarter. Stone House Investment Management LLC lifted its stake in shares of IonQ by 700.0% in the third quarter. Stone House Investment Management LLC now owns 400 shares of the company’s stock worth $25,000 after acquiring an additional 350 shares in the last quarter. Ameriflex Group Inc. boosted its holdings in IonQ by 485.7% in the third quarter. Ameriflex Group Inc. now owns 410 shares of the company’s stock valued at $25,000 after purchasing an additional 340 shares during the last quarter. Hilltop National Bank boosted its holdings in IonQ by 112.5% in the third quarter. Hilltop National Bank now owns 425 shares of the company’s stock valued at $26,000 after purchasing an additional 225 shares during the last quarter. Finally, Accent Capital Management LLC grew its stake in IonQ by 171.8% during the 4th quarter. Accent Capital Management LLC now owns 587 shares of the company’s stock valued at $26,000 after purchasing an additional 371 shares in the last quarter. Institutional investors and hedge funds own 41.42% of the company’s stock.
Key Stories Impacting IonQ
- Positive Sentiment: IonQ’s planned acquisition of SkyWater (announced earlier in 2026) is being framed as a move to create a vertically integrated, full‑stack quantum company, potentially accelerating fault‑tolerant roadmap, increasing combined revenue scope and lowering manufacturing costs — a strategic growth catalyst. The SkyWater Deal: IonQ’s Bid for Quantum Supremacy
- Positive Sentiment: The U.K.’s €2 billion (~$2.5B) quantum program plus IonQ’s strategic partnership with Cambridge University (IonQ Quantum Innovation Centre to host a 256‑qubit machine) provide government R&D spending and validation that could boost adoption, contracts and regional expansion. U.K. to Spend $2.5 Billion on Quantum Computing
- Positive Sentiment: Analyst and coverage notes highlight concrete 2026 commercialization targets (management sees $225M+ revenue, global expansion and technical milestones), reinforcing the narrative that IonQ is moving from validation toward revenue scaling. Key Catalysts Supporting IonQ’s Growth Through 2026
- Neutral Sentiment: Market write‑ups note the stock’s recent pullback and volatility (coverage highlighting share moves), which is informational for traders but not new fundamental news. IonQ Declines More Than Market
- Neutral Sentiment: Investor commentary (The Motley Fool) praises IonQ’s leadership in trapped‑ion qubits but reminds readers it remains an early‑stage, high‑risk growth story—useful context for position sizing. Is It Too Late to Buy IonQ Stock?
- Negative Sentiment: Insider selling was disclosed (John Raymond sold 2,800 shares in mid‑March). The sale is small relative to institutional holdings but can be perceived negatively by short‑term traders. Insider Selling: IonQ Insider Sells 2,800 Shares
- Negative Sentiment: Macro and risk‑off factors (oil/inflation concerns) and IonQ’s negative operating cash flow / deal financing needs are flagged as headwinds for a high‑beta growth stock — these amplify downside if markets turn risk‑averse. Macro Risk for Quantum Stocks
Wall Street Analysts Forecast Growth
A number of research analysts have commented on IONQ shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of IonQ in a research report on Thursday, January 22nd. DA Davidson lowered their target price on IonQ from $55.00 to $35.00 and set a “neutral” rating for the company in a research note on Thursday, February 26th. Morgan Stanley set a $37.00 target price on IonQ in a report on Thursday, February 26th. Benchmark reduced their price target on IonQ from $75.00 to $65.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Rosenblatt Securities restated a “buy” rating and issued a $100.00 price target on shares of IonQ in a report on Thursday, February 26th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, IonQ has a consensus rating of “Moderate Buy” and an average price target of $69.45.
Check Out Our Latest Stock Report on IonQ
About IonQ
IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.
Further Reading
Receive News & Ratings for IonQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IonQ and related companies with MarketBeat.com's FREE daily email newsletter.
